HCAHCA Healthcare, Inc.

NYSE hcahealthcare.com


$ 319.17 $ -0.41 (-0.13 %)    

Wednesday, 24-Apr-2024 15:59:59 EDT
QQQ $ 422.96 $ 1.44 (0.34 %)
DIA $ 384.57 $ -0.58 (-0.15 %)
SPY $ 502.89 $ -0.24 (-0.05 %)
TLT $ 88.37 $ -0.63 (-0.71 %)
GLD $ 214.61 $ -0.40 (-0.19 %)
$ 319.02
$ 319.11
$ 0.00 x 0
$ 319.09 x 100
$ 317.70 - $ 321.62
$ 215.03 - $ 335.83
835,473
na
88.18B
$ 1.42
$ 16.82
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-16-2024 12-31-2023 10-K
2 10-26-2023 09-30-2023 10-Q
3 08-02-2023 06-30-2023 10-Q
4 04-27-2023 03-31-2023 10-Q
5 02-17-2023 12-31-2022 10-K
6 11-01-2022 09-30-2022 10-Q
7 08-01-2022 06-30-2022 10-Q
8 05-03-2022 03-31-2022 10-Q
9 02-18-2022 12-31-2021 10-K
10 11-01-2021 09-30-2021 10-Q
11 08-02-2021 06-30-2021 10-Q
12 04-30-2021 03-31-2021 10-Q
13 02-19-2021 12-31-2020 10-K
14 10-29-2020 09-30-2020 10-Q
15 07-30-2020 06-30-2020 10-Q
16 05-06-2020 03-31-2020 10-Q
17 02-20-2020 12-31-2019 10-K
18 11-01-2019 09-30-2019 10-Q
19 08-02-2019 06-30-2019 10-Q
20 05-03-2019 03-31-2019 10-Q
21 02-21-2019 12-31-2018 10-K
22 11-06-2018 09-30-2018 10-Q
23 08-03-2018 06-30-2018 10-Q
24 05-08-2018 03-31-2018 10-Q
25 02-23-2018 12-31-2017 10-K
26 11-07-2017 09-30-2017 10-Q
27 08-04-2017 06-30-2017 10-Q
28 05-09-2017 03-31-2017 10-Q
29 02-22-2017 12-31-2016 10-K
30 11-03-2016 09-30-2016 10-Q
31 08-04-2016 06-30-2016 10-Q
32 05-06-2016 03-31-2016 10-Q
33 02-26-2016 12-31-2015 10-K
34 10-29-2015 09-30-2015 10-Q
35 08-05-2015 06-30-2015 10-Q
36 05-05-2015 03-31-2015 10-Q
37 02-26-2015 12-31-2014 10-K
38 11-04-2014 09-30-2014 10-Q
39 08-05-2014 06-30-2014 10-Q
40 05-06-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 studies-led-by-harvard-pilgrim-health-care-institute-hca-healthcare-and-the-university-of-california-irvine-announce-two-clinical-trials-identified-a-better-way-to-target-appropriate-antibiotics-for-patients-hospitalized-with-pneumonia-or-urinary-tract-infection

Algorithm driven alerts help identify best antibiotic for patients with common infections in two 59-hospital trials, with impli...

 deutsche-bank-maintains-buy-on-hca-healthcare-raises-price-target-to-359

Deutsche Bank analyst Pito Chickering maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $330 t...

 cantor-fitzgerald-reiterates-overweight-on-hca-healthcare-maintains-335-price-target

Cantor Fitzgerald analyst Sarah James reiterates HCA Healthcare (NYSE:HCA) with a Overweight and maintains $335 price target.

 wells-fargo-maintains-equal-weight-on-hca-healthcare-raises-price-target-to-315

Wells Fargo analyst Stephen Baxter maintains HCA Healthcare (NYSE:HCA) with a Equal-Weight and raises the price target from ...

 barclays-initiates-coverage-on-hca-healthcare-with-overweight-rating-announces-price-target-of-356

Barclays analyst Andrew Mok initiates coverage on HCA Healthcare (NYSE:HCA) with a Overweight rating and announces Price Tar...

 cantor-fitzgerald-reiterates-overweight-on-hca-healthcare-maintains-335-price-target

Cantor Fitzgerald analyst Sarah James reiterates HCA Healthcare (NYSE:HCA) with a Overweight and maintains $335 price target.

 hca-healthcares-sarah-cannon-cancer-institute-implements-new-outpatient-model-for-car-t-cell-therapy

HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that the Sarah Cannon Ca...

Core News & Articles

One of the nation's leading providers of healthcare services to migrate certain on-premises operational workloads to Vantag...

 2008-big-short-oracle-burry-bets-big-on-chinese-giants-backs-google-amazons-ai-wave

Michael Burry, the visionary investor, made significant changes to his portfolio in Q4 2023. Increased stakes in Chinese retail...

Core News & Articles

https://www.sec.gov/Archives/edgar/data/1649339/000090514824000653/xslForm13F_X02/informationtable.xml

 truist-securities-maintains-buy-on-hca-healthcare-raises-price-target-to-345

Truist Securities analyst David Macdonald maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $3...

 rbc-capital-maintains-outperform-on-hca-healthcare-raises-price-target-to-322

RBC Capital analyst Ben Hendrix maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $308 ...

 raymond-james-maintains-outperform-on-hca-healthcare-raises-price-target-to-330

Raymond James analyst John Ransom maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $30...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION